Showing results (271-280 of 336) with videos related to
Sort By:
Pageof 34
Cancer Science|August 5, 2009
Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatmentMasaru Jida, Shinichi Toyooka, Tetsuya Mitsudomi, et al.Cancer|December 5, 2018
Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studiesMyung-Ju Ahn, Chun-Ming Tsai, Frances A Shepherd, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2023
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 InsertionAkira Hamada, Kenichi Suda, Masaya Nishino, et al.JTO Clinical and Research Reports|February 24, 2025
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory StudyShuta Ohara, Kenichi Suda, Sumedha Sudhaman, et al.JTCVS Open|July 10, 2023
Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective studyAkira Hamada, Kazuhiro Kitajima, Kenichi Suda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancerShinichi Toyooka, Keitaro Matsuo, Hisayuki Shigematsu, et al.The Annals of Thoracic Surgery|July 3, 2020
Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer CasesKenichi Suda, Tetsuya Mitsudomi, Yasushi Shintani, et al.Clinical Lung Cancer|May 26, 2021
Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L)Akira Hamada, Junichi Soh, Akito Hata, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2025
Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)Akira Hamada, Junichi Soh, Akito Hata, et al.Scientific Reports|August 7, 2019
A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencingKazuko Sakai, Masayuki Takeda, Shigeki Shimizu, et al.Pageof 34